SAN DIEGO, May 3, 2011 /PRNewswire via COMTEX/ --
BioMed Realty Trust, Inc. (NYSE: BMR) announced today the signing of a new lease with Logitech, Inc. (SIX: LOGN) (Nasdaq: LOGI) at its Pacific Research Center in Newark, California. Logitech, a world leader in products that connect people to the digital experiences they care about, agreed to a lease for 263,543 square feet of office space through February 2023 at BioMed's multi-tenant campus in San Francisco's East Bay.
During the last twelve months, BioMed has leased over 387,000 square feet at the Pacific Research Center. The Pacific Research Center has proven itself as a high quality campus in an excellent location attracting thriving life science and technology companies.
Ron Haskins, Logitech's Vice President of Real Estate, remarked, "We at Logitech are excited to locate our operations at the Pacific Research Center. The conveniently located, high-quality facilities include important amenities for our employees in an attractive campus environment."
"We are very pleased that Logitech has chosen the Pacific Research Center for its U.S. corporate headquarters," said Alan D. Gold, Chairman and Chief Executive Officer of BioMed. "As a world leader in personal computer navigation, Internet communications, digital music, home-entertainment control, gaming and wireless devices, Logitech's commitment to managing its Silicon Valley operations at the Pacific Research Center exemplifies the diverse and dynamic organizations that are driving innovation from this unique campus in the East Bay."
Logitech is a world leader in products that connect people to the digital experiences they care about. Spanning multiple computing, communication and entertainment platforms, Logitech's combined hardware and software enable or enhance digital navigation, music and video entertainment, gaming, social networking, audio and video communication over the Internet, video security and home-entertainment control. Founded in 1981, Logitech International is a Swiss public company listed on the SIX Swiss Exchange (LOGN) and on the Nasdaq Global Select Market (LOGI).
Logitech, the Logitech logo, and other Logitech marks are registered in Switzerland and other countries. All other trademarks are the property of their respective owners. For more information about Logitech and its products, visit the company's Web site at www.logitech.com.
About BioMed Realty Trust
BioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused on Providing Real Estate to the Life Science Industry®. The company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed owns or has interests in 85 properties, representing 147 buildings with approximately 12.2 million rentable square feet. The company's properties are located predominantly in the major U.S. life science markets of Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/New Jersey, which have well-established reputations as centers for scientific research. Additional information is available at www.biomedrealty.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 based on current expectations, forecasts and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially. These risks and uncertainties include, without limitation: general risks affecting the real estate industry (including, without limitation, the inability to enter into or renew leases, dependence on tenants' financial condition, and competition from other developers, owners and operators of real estate); adverse economic or real estate developments in the life science industry or the company's target markets; risks associated with the availability and terms of financing, the use of debt to fund acquisitions and developments, and the ability to refinance indebtedness as it comes due; failure to maintain the company's investment grade credit ratings with the ratings agencies; failure to manage effectively the company's growth and expansion into new markets, or to complete or integrate acquisitions and developments successfully; reductions in asset valuations and related impairment charges; risks and uncertainties affecting property development and construction; risks associated with downturns in the national and local economies, increases in interest rates, and volatility in the securities markets; potential liability for uninsured losses and environmental contamination; risks associated with the company's potential failure to qualify as a REIT under the Internal Revenue Code of 1986, as amended, and possible adverse changes in tax and environmental laws; and risks associated with the company's dependence on key personnel whose continued service is not guaranteed. For a further list and description of such risks and uncertainties, see the reports filed by the company with the Securities and Exchange Commission, including the company's most recent annual report on Form 10-K and quarterly reports on Form 10-Q. The company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
SOURCE BioMed Realty Trust, Inc.